Zachęcamy do zapoznania się z najczęsciej cytowanymi artykułami Calcified Tissue International oraz Osteoporosis International. 

Wśród artykułów z Osteoporosis International w 2016 roku na liście znalazły się: 
- Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
Weaver, C.M., Alexander, D.D., Boushey, C.J. et al. Osteoporos Int (2016) 27: 367
 
- Age-associated declines in muscle mass, strength, power, and physical performance: impact on fear of falling and quality of life
Trombetti, A., Reid, K.F., Hars, M. et al. Osteoporos Int (2016) 27: 463. 
 
- Proton-pump inhibitors and risk of fractures: an update meta-analysis
Zhou, B., Huang, Y., Li, H. et al. Osteoporos Int (2016) 27: 339.
 
- Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports
Aubry-Rozier, B., Gonzalez-Rodriguez, E., Stoll, D. et al. Osteoporos Int (2016) 27: 1923. 
 
- Impact of hip fracture on hospital care costs: a population-based study
Leal, J., Gray, A.M., Prieto-Alhambra, D. et al. Osteoporos Int (2016) 27: 549.
 
- Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate
Nakayama, A., Major, G., Holliday, E. et al. Osteoporos Int (2016) 27: 873. 
 
- Relationship of sarcopenia and body composition with osteoporosis
He, H., Liu, Y., Tian, Q. et al. Osteoporos Int (2016) 27: 473.
 
- A systematic review and meta-analysis of the association between eating disorders and bone density
Robinson, L., Aldridge, V., Clark, E.M. et al. Osteoporos Int (2016) 27: 1953. 

Wśród artykułów, które były najczęściej cytowane w Calcified Tissue International wskazano: 

- Alkaline Phosphatase and Hypophosphatasia
Millán, J.L. & Whyte, M.P. Calcif Tissue Int (2016) 98: 398. 

- Pharmacologic Options for the Treatment of Sarcopenia
Morley, J.E. Calcif Tissue Int (2016) 98: 319.

- Sclerostin Inhibition in the Management of Osteoporosis
Appelman-Dijkstra, N.M. & Papapoulos, S.E. Calcif Tissue Int (2016) 98: 370.

- Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures
Nemeth, E.F. & Goodman, W.G. Calcif Tissue Int (2016) 98: 341.

- SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture
Kanis, J.A., Compston, J., Cooper, C. et al. Calcif Tissue Int (2016) 98: 417.

- Cathepsin K Inhibition: A New Mechanism for the Treatment of Osteoporosis
Duong, L.T., Leung, A.T. & Langdahl, B. Calcif Tissue Int (2016) 98: 381. 

- Bone Microarchitecture in Men and Women with Diabetes: The Importance of Cortical Porosity
Paccou, J., Ward, K.A., Jameson, K.A. et al. Calcif Tissue Int (2016) 98: 465.

- Effects of Dairy Products Consumption on Health: Benefits and Beliefs-A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Rozenberg, S., Body, JJ., Bruyère, O. et al. Calcif Tissue Int (2016) 98: 1. 

Żródło: www.iofbonehealth.org/news

Program Naukowy Kongresu w zakresie doniesień ustnych – kompletny. Organizatorzy informują o rekordowej, względem poprzednich edycji, liczbie zgłoszonych abstraktów – 1513 zgłoszeniach! 

Doniesienia zostaną zaprezentowane zarówno w formie wykładów jak i plakatów. Doniesienia ustne przedstawione zostanę w ramach 10 wykładów plenarnych, 4 wykładów specjalnych, 13 Sesji z Ekspertem, 7 sympozji ESCEO oraz 29 niesponosorowanych sympozji. Z uwagi na swój szeroki zakres tematyczny program adresowany jest do specjalistów różnych dziedzin medycyny. Uczestnicy liczyć mogą na 16 punktów edukacyjnych CME.

W ramach programu zaplanowano nastepujące sesje niesponsorowane:
Piątek 20.04.18
– Breast Cancer and Bone Health – Joint session of the Cancer & Bone Society (CABS) and IOF
– Sarcopenia: Problem-solving a new lifestyle disease
-Bone fragility in diabetes
– Treating Osteosarcopenia by Targeting Muscle and Bone: Actuality &  Perspectives
– Global Map of Dietary Calcium Intake reveals large geographic regions of low intake – a call to action

Sobota 21.04.18
– Complex Regional Pain Syndrome: Facts on Causes, Diagnosis and Therapy
– Achieving gender equity in musculoskeletal science – why it matters and how can we do it?
– Demonstrating fracture liaison service effectiveness – Use of fracture incidence & prescribing data to demonstrate clinical and cost effectiveness in a small population
– Mediterranean diet & musculoskeletal diseases
– DO-HEALTH: First results of a large European Trial
– ASBMR-IOF-ESCEO Symposium: Closing the Treatment Gap
– Clinical Application of Bone Markers
– Joint IOF ESCEO FFN Secondary Fracture Prevention / FLS
– Management of Bone Health Throughout Women’s Life Span. Gynecological Perspective on Effective Prevention of Osteoporosis Fragility Fracture
– Optimising bone health, muscle strength and balance in middle-aged women: new opportunities for long-term fracture prevention
– Musculo-skeletal Imaging by clinical microCT
– A contemporary approach in education: Developing the role of nurses working in secondary fracture prevention

Niedziela 22.04.18
– Taking care of the osteoporotic spine
– Optimisation of Fracture Liaison Services
– Impact of osteoporosis/osteopenia in management of osteoarthritis
– Novelty regarding the potential of nutritional interventional studies with or without exercise training to prevent muscle function in older adults
– Management of Osteoporosis – Closing the gap in the CEE countries
– Diabetes and Osteoporosis: A sweet relationship
– Management of Osteoporosis in Poland
– Physical activity and rehabilitation in osteoporosis and sarcopenia
– Identification of vertebral fractures in Fracture Liaison Services in the UK
– Rational approach to osteoporosis in Turkey
– Autoimmune Sarcopenia
– Non-irradiating evaluation of bone mineral mass at peripheral and axial sites

Więcej informacji oraz rejestracja pod adresem www.